GB Meka
Stocks to watch

VZ

Compare

VERIZON COMMUNICATIONS INC · Communication Services

$45.93
▼ 0.1%Close 2026-09-30

Live intraday price

Compare with our price levels

T249.97
T148.20
E143.42
E337.84
SL36.79

Close 2026-09-30: $45.93 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting• Neutral

Not in the buy zone yet — needs to drop 5.5% · 1 whale recently bought

1 month
▼ 8.2%
3 months
▲ 11.3%
1 year
▲ 13.5%
Analyst target
$51.56 +12.2%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$43.42 -5.5%
E2$40.08 -12.8%
E3$37.84 -17.6%
Targets
T1$48.20 4.9%
T2$49.97 8.8%
T3$50.93 10.9%
Stop-loss
SL$36.79 -19.9%
Whale cost ~$43.42 -5.5%

Risk : reward 1 : 2.6Moves ~$1.06 a day

⚖️ Positives and risks

✓ Positives (3)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
  • ●แนวโน้มระยะยาวเป็นขาขึ้น (เหนือ MA200 และ MA200 ชี้ขึ้น)
  • ●นักวิเคราะห์ส่วนใหญ่แนะนำ Buy
! Risks (4)
  • ●เซียนขายออก/ลดสัดส่วน 2 ราย: Joel Greenblatt (ลด), Bill Miller (ลด)
  • ●อ่อนแอกว่าตลาด (S&P 500) -24% ใน 6 เดือน
  • ●รายได้หดตัว -1% เทียบปีก่อน
  • ●กำไรหดตัว -22% เทียบปีก่อน

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

Malady Kyle · CEO

2026-09-22 · 1,100 shares @ $47.65 · pre-planned sale (10b5-1)

$52,415
Sell

Malady Kyle · CEO

2026-09-15 · 1,100 shares @ $51.19 · pre-planned sale (10b5-1)

$56,309
Sell

Malady Kyle · CEO

2026-09-08 · 1,100 shares @ $49.98 · pre-planned sale (10b5-1)

$54,978
Sell

Malady Kyle · CEO

2026-09-01 · 1,100 shares @ $50.50 · pre-planned sale (10b5-1)

$55,550
Sell

Malady Kyle · CEO

2026-08-25 · 1,100 shares @ $50.06 · pre-planned sale (10b5-1)

$55,066
Sell

Malady Kyle · CEO

2026-08-18 · 1,100 shares @ $48.68 · pre-planned sale (10b5-1)

$53,548
Sell

Hammock Samantha · Officer

2026-05-29 · 73,069 shares @ $47.83

$3M
Sell

Stillwell Mary-Lee · Officer

2026-03-02 · 8,569 shares @ $50.00 · pre-planned sale (10b5-1)

$428,450
Sell

Vestberg Hans Erik · Director

2026-02-24 · 200,000 shares @ $49.61

$10M
Sell

Vestberg Hans Erik · Director

2026-02-24 · 12,500 shares @ $49.61

$620,175
Sell

Russo Joseph J. · Officer

2026-02-02 · 9,579 shares @ $44.88

$429,906

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

🤖 The paper-trading bot has traded this stock

All bot results
2026-06-30 → 2026-08-13 · ครบกำหนดถือ▲ 14.1%

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$195.6B
Next earnings2026-10-20
P/E (price to earnings)12.3
Forward P/E (on expected earnings)8.9
Revenue growth (YoY)-0.7%
Earnings growth (YoY)-22.0%
Net profit margin+11.6%
ROE+15.8%
Debt to equity (D/E)184%
Dividend yield6.01%
Analyst targets (high / low)$71.00 / $44.00
Number of analysts23
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Sideways → · Uptrend ↗
RSI34
MA50 / MA200$48.24 / $45.49
Distance from MA200+1.0%
MACDNegative
1-year high / low$51.67 / $36.55
vs. S&P 500 (6 months)-24.2%
Volume vs. average0.18×